Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Galectin Therapeutics GAAP EPS of -$0.04 beats by $0.01

We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at seekingalpha.com →

More in Finance & Markets

Why Marvell Stock Is Down Today

Investors appear to be stepping back from AI stocks ahead of Nvidia's earnings, and Marvell's pending all-stock Lumentum deal adds dilution risk on top of that.

  • Marvell stock down 6.4% on Nov 16
  • Nvidia CEO Jensen Huang's departure
  • Lumentum acquisition causing dilution

Monday links: the end of some eras

Markets How the AI trade is unwinding. (wsj.com) Many of 2026's biggest IPOs have come back to earth. (ft.com) The market has (kinda) shrugged off Nvidia's ($NVDA) problems.

  • AI IPOs returning to reality, despite Nvidia struggles
  • Kalshi's growth to $100B sparks societal discussion
  • Nvidia CEO Jensen Huang's downfall marks tech era end

More from Monday 16 November →